CareLit · DOI-Nachweis · Ultraschall in der Medizin - European Journal of Ultrasound
CHARACTERIZATION AND DETECTION OF HEPATOCELLULAR CARCINOMA: COMPARISON BETWEEN THE ULTRASOUND CONTRAST AGENTS SONOVUE AND LEVOVIST: WHICH ONE IS BETTER?
DOI 10.1055/s-2005-917332
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Von Herbay, C Vogt, D Häussinger, M Gregor
ZeitschriftUltraschall in der Medizin - European Journal of Ultrasound
Ausgabe09/2005
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Purpose: SonoVue (Altana Pharma, Konstanz) and Levovist (Schering AG, Berlin) are both contrast agents, which are helpful in characterization and detection of malignant liver lesions. This study was performed to find out, which of both contrast agents is better in the diagnosis of hepatocellular carcinoma (HCC). Methods and Materials: In a prospective study 63 patients with histological proof of hepatocellular carci…
Zitieren
Zitierempfehlung
A Von Herbay, C Vogt, D Häussinger, M Gregor (2005) CHARACTERIZATION AND DETECTION OF HEPATOCELLULAR CARCINOMA: COMPARISON BETWEEN THE ULTRASOUND CONTRAST AGENTS SONOVUE AND LEVOVIST: WHICH ONE IS BETTER?. Ultraschall in der Medizin - European Journal of Ultrasound (09). https://doi.org/10.1055/s-2005-917332
Mit CareLit weiterarbeiten